CASP14 and Alzheimer disease: Caspase-14 deficiency has been reported to promote parakeratosis in skin equivalent models treated with siRNA and in knockout mice.27, 28 Interestingly, parakeratosis has also been described in some AD patients,29, 30 in particular in skin regions where caspase-14 was not detected.28